Paige unveils breast lymph node software at USCAP 2022

By LabPulse.com staff writers

March 22, 2022 -- Artificial intelligence (AI)-based software developer Paige has unveiled its breast lymph node application at this week's United States and Canadian Academy of Pathology (USCAP) annual meeting in Los Angeles.

Designed to help pathologists detect if breast cancer has metastasized to the lymph nodes, Paige Breast Lymph Node can yield 98% slide-level sensitivity for detecting metastases of any size, according to the vendor. The software's TissueMap tool highlights all regions on a slide that are suspicious for cancer, and both slides and cases with suspected positive lymph nodes are highlighted to facilitate priority review by pathologists, Paige said.

Paige Breast Lymph Node is currently available in the U.S. for research-use only.

Paige links with Flagship on biomarker analysis tools
Pathology artificial intelligence software developer Paige has inked a partnership with Flagship Biosciences that makes Flagship's diagnostics software...
Paige partners with Mindpeak for AI breast cancer software
Paige and Mindpeak have announced a distribution partnership that will enable pathologists to use Mindpeak's BreastIHC artificial intelligence (AI) software...
Paige appoints new executives
Artificial intelligence software developer Paige announced that it has appointed new executive leaders, including Andy Moye, PhD, as CEO and Jill Stefanelli,...
Paige AI software gets U.K. medtech innovation evaluation
The U.K.'s National Institute for Health and Care Excellence (NICE) has published a Medtech Innovation Briefing (MIB) on Paige's Paige Prostate artificial...
FDA clears 1st prostate pathology AI software application
The U.S. Food and Drug Administration (FDA) has authorized marketing of Paige.ai's Paige Prostate artificial intelligence (AI) software, the first prostate...

Copyright © 2022 LabPulse.com

Last Updated ka 3/22/2022 3:06:23 PM